Top Highlights for June 2015:
- AstraZeneca and Sun Pharma ink distribution deal for ticagrelor in India to serve larger number of ACS patients in India.
- US based Golden Helix collaborates with India’s MedGenome for better tailor diagnostic and therapeutic strategies to individual patients.
- India based Avesthagen,enters into licensing agreement with Queensland University of Technology (QUT) for making migraine therapy a reality.
- Sequoia pumps USD 16 Mn for R&D and further expansion of India's La Renon Healthcare.
- Fidelity Growth Partners invest USD 10 Mn in India based Medwell Ventures, with plans to expand rapidly across the country.
- Taiwan based Apex eyes acquisitions in India after grand entry into the Indian market in May 2015, through its initial investments worth USD 16 Mn.
- US-based Inspirata, a cancer diagnostics solution provider enters India with their first R&D facility in Bangalore.
- Sinopharm to launch 6 new products in India soon; more partnerships with Indian Govt. and Indian companies on the cards.
For more such news and updates, please join our Group "Global Life Science Business in India" on LinkedIn.
Aagami Updates:
- Aagami's latest Company Presentation and Case Studies are available on its company website.
- Aagami CEO returns from 2015 BIO International Convention at Philadelphia; Many out of the 50+ meetings proved fruitful.
- Aagami to bring New Zealand client to India in August 2015 for finalizing licensing partnership(s).